There have been so many dates thrown around at this point, how can anyone believe any of them.Someone on Reddit posted that the unblinding date appears to be Feb 12. If that's true, the FDA has had the raw data for a long time which augers well for CYDY IMO.
There's a lot to be said for the first efficacious drug out of the gate. Isn't HGEN and RLFTF closing in on results also (regarding the day 60 results)?Someone on Reddit posted that the unblinding date appears to be Feb 12. If that's true, the FDA has had the raw data for a long time which augers well for CYDY IMO.
Let's start pretending they get an EUA, how quickly do we think the price will run up at open. If you get market price early enough, you should still see gains from a lot of the run up (i would expect)
Not sure why I'm holding so much of this risky stuff when I can still capitlize on a lot of the run up.
I think it would get to $15 pretty quick. Not sure who would sell shares though. They are a stubborn group of investors. And no one would be borrowing shares to short.Let's start pretending they get an EUA, how quickly do we think the price will run up at open. If you get market price early enough, you should still a lot of the run up (i would expect)
Not sure why I'm holding so much of this risky stuff when I can still get in on a lot of the run up.
Somebody would take profits.I think it would get to $15 pretty quick. Not sure who would sell shares though. They are a stubborn group of investors. And no one would be borrowing shares to short.
This is kind of what I was thinking and maybe see a run of $10 to $20 (at least)Somebody would take profits.
Actually thought today if the results were great I could probably get it at $10 before it really ran up, with none of the risk. But this can be such a popular stock that I’m not sure that’s true.
Would you sell for $10 if it got approval? So few people would be taking profits at that level.Somebody would take profits.
Actually thought today if the results were great I could probably get it at $10 before it really ran up, with none of the risk. But this can be such a popular stock that I’m not sure that’s true.
Yeah, that's a good point. Not sure how much would be available.Would you sell for $10 if it got approval? So few people would be taking profits at that level.
No ####### way. I’m waiting for three digits babyWould you sell for $10 if it got approval? So few people would be taking profits at that level.
You have to take a lot of leaps to connect the dots.I've been gone for a while and have been enjoying life not contemplating what the #### Nader could possibly be thinking.
I'm seeing folks seemingly optimistic. Is this similar to when starving people start hallucinating about steaks or should I light fire to my previous profits and get back in?
Arguments on both sides. To me, the simple fact that the FDA has had unblinded data for at a minimum a week, possibly more, and have kept OLE is telling. I’m hanging my hat on that frankly. If the data was negative, they’d pull it. They haven’t. And that’s all I have to say about that.I've been gone for a while and have been enjoying life not contemplating what the #### Nader could possibly be thinking.
I'm seeing folks seemingly optimistic. Is this similar to when starving people start hallucinating about steaks or should I light fire to my previous profits and get back in?
The short squeeze will be epic and could cause some crazy swings in the stock. I'd suggest longs watch and be ready to take advantage.Yeah, that's a good point. Not sure how much would be available.
I would probably unload some in the $20-$25 range for sure though
OLE is a good argument for but it's just another black box to me, no clue how much this is being used, if at allArguments on both sides. To me, the simple fact that the FDA has had unblinded data for at a minimum a week, possibly more, and have kept OLE is telling. I’m hanging my hat on that frankly. If the data was negative, they’d pull it. They haven’t. And that’s all I have to say about that.
Very good question. You'd think there would have been some kind of leak but also remember that big pharma pays big $ to lobbyists to keep small companies out. NP has a terrible reputation within the industry and the regulators. This is a "show me that it works" situation IMO.Why hasn't one reporter from a major news source got a sniff that there may be a good story here?
Or why isn't it crashing if the data is bad?There are always leaks, why isn't this stock moving positively at this point?
Now this is getting interesting.....The short squeeze will be epic and could cause some crazy swings in the stock. I'd suggest longs watch and be ready to take advantage.
I am thinking about buying back 100k shares tomorrow.
There's been solid support on just about every dip for a month now.Or why isn't it crashing if the data is bad?
Cause most people are holding in the off chance NP delivers. I don't think anyone left doubts CYDY has huge potential, but I think we all just differ on the odds of that happening.Or why isn't it crashing if the data is bad?
Seems like it would be more likely that there would be forward price movement than backwards. We'd have to assume whoever is on the receiving end of this info would have something to even sell. However if positive, a new person would surely buy in.Or why isn't it crashing if the data is bad?
I have a journalism degree and background. If you were a reporter what angle would you cover this from? You don’t have any data. CD 10 went nowhere. The ceo doesn’t seem competent. What’s the story you’re writing as a journalist and not a stakeholder?The lack of media interest is going to be the one thing that if this gets shot down, I'm going to be mad at myself for not going with my gut. It just doesn't make any sense to me.
If the results are going to be great I can't come up with one good reason why it hasn't got coverage yet. The media is desperately looking for some good news to counter some of the gloom. Certainly not every reporter is beholden to big pharma.
If Nader gives off a vibe that the media won't even touch, that's not a good sign either. They won't even talk to Patterson though, why aren't they curious?
I've tried to get the word out, no one will bite. If there is coverage, it's either a local station or it's generally unfavorable from the likes of Stat News.
Now if the results are middle of the road, this makes a lot more sense.
Incompetent CEO stumbles getting potential life saving drug to market.I have a journalism degree and background. If you were a reporter what angle would you cover this from? You don’t have any data. CD 10 went nowhere. The ceo doesn’t seem competent. What’s the story you’re writing as a journalist and not a stakeholder?
This drug is sitting with the FDA for an approval decision, I think I might mention it somewhere, especially if I'm regularly covering therapeutics and vaccines.I have a journalism degree and background. If you were a reporter what angle would you cover this from? You don’t have any data. CD 10 went nowhere. The ceo doesn’t seem competent. What’s the story you’re writing as a journalist and not a stakeholder?
That’s not news, just speculation. No editor/publisher is going to go with that. A biotech company in a trial with no results posted isn’t news.This drug is sitting with the FDA for an approval decision, I think I might mention it somewhere, especially if I'm regularly covering therapeutics and vaccines.
I'd cover it from the angle of an underdog company that no one has ever heard of that is on the verge of making a splash in the market.
I'd start talking to Doctors who are close to this and get more information about a novel way to fight infection.
There is a story here and anyone close to the FDA, the prescription drug market would want to cover it at this point.
If this news is going to be great, people talk. There are certainly reporters who have ins at the FDA who are going to find out things. That nothing has been leaked is insane at this point. Only if the results are mediocre, then perhaps no one will have anything to talk about.That’s not news, just speculation. No editor/publisher is going to go with that. A biotech company in a trial with no results posted isn’t news.
NP doesn't pass the smell test. He comes off like a used car salesman. Couple that with the fact that big pharma companies are huge advertisers in all media and you have your answer as to why there's been little/no coverage of CYDY. The FDA has to approve LL and then there will be coverage. Also, there are dozens of companies saying that they've got a solution for COVID--how is an untrained reporter supposed to parse the good from the bad?If this news is going to be great, people talk. There are certainly reporters who have ins at the FDA who are going to find out things. That nothing has been leaked is insane at this point. Only if the results are mediocre, then perhaps no one will have anything to talk about.
I don’t think there are many leaks at the fda. Certainly not to the point where they are discussing results. I’m sure there are journalists aware of the story who will break it when results are out but there is nothing to go to your editor with right now. There just isn’t.If this news is going to be great, people talk. There are certainly reporters who have ins at the FDA who are going to find out things. That nothing has been leaked is insane at this point. Only if the results are mediocre, then perhaps no one will have anything to talk about.
If there is something here, it should be getting coverage. Even if its just a story to introduce it, someone is going to want to be close to it, regardless if they have material news or not
Just 2 more weeks....Man. I just want this to be over with one way or another.
I know people who've been in CYDY for 5+ years.Just 2 more weeks....
I think you mean 130 two-weeks.I know people who've been in CYDY for 5+ years.
It means you should do as I do instead of following your gut.I’m not sure what this means but this is making a big move while Hgen plummets.